Mental illnesses are commonly encountered in primary care practice. Yet their sufferers are often relegated to mischaracterized roles of "problem patients" due to the impacts of their diseases on thoughts and behaviors. How can clinicians improve their approach to patients will mental health issues, and can this approach be duplicated at community-wide levels? Speaking on this important initiative is Dr. Marilyn B. Benoit, Chief Clinical Officer and Senior Vice President of Clinical and Professional Affairs at Devereux, one of the nation's premier nonprofit behavioral healthcare organizations. Dr. Benoit is a nationally-known and highly-respected child and adolescent psychiatrist with a wide-ranging career both as a practicing physician and a health care administrator in public, private and academic settings.
Overcoming Ignorance and Stigmatization of Mental Illness in Primary Care

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Mental illnesses are commonly encountered in primary care practice. Yet their sufferers are often relegated to mischaracterized roles of "problem patients" due to the impacts of their diseases on thoughts and behaviors. How can clinicians improve their approach to patients will mental health issues, and can this approach be duplicated at community-wide levels? Speaking on this important initiative is Dr. Marilyn B. Benoit, Chief Clinical Officer and Senior Vice President of Clinical and Professional Affairs at Devereux, one of the nation's premier nonprofit behavioral healthcare organizations. Dr. Benoit is a nationally-known and highly-respected child and adolescent psychiatrist with a wide-ranging career both as a practicing physician and a health care administrator in public, private and academic settings.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolving Our View of the Coagulation Cascade and Stroke Management
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
M3: Managing the Cardiometabolic Risk in MASH
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
HF Management for Patients with Comorbid Conditions
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?